Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial)

• Main Authors: Scherjon Sicco A (Author), Lotgering Fred K (Author), van Pampus Maria G (Author), Opmeer Brent C (Author), Kwee Anneke (Author), van Eyck Jim (Author), Duvekot Johannes J (Author), Derks Jan B (Author), Cornette Jérôme (Author), Bolte Annemiek C (Author), Bloemenkamp Kitty WM (Author), Scheepers Hubertina CJ (Author), Porath Martina M (Author), Oudijk Martijn A (Author), Wilms Femke F (Author), Vis Jolande Y (Author), Sollie Krystyna M (Author), Spaanderman Marc EA (Author), Willekes Christine (Author), van der Post Joris AM (Author), Mol Ben (Author)
• Format: Book
• Published: BMC, 2009-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>At present, women with threatened preterm labor before 32 weeks of gestation are, after transfer to a perinatal center, treated with tocolytics and corticosteroids. Many of these women are treated unnecessarily. Fibronectin is an acc...